跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
戴 世光
教授
醫學系耳鼻喉學科
電子郵件
sktai
vghtpe.gov
tw
h-index
h10-index
h5-index
3534
引文
31
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
915
引文
14
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
195
引文
7
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1997 …
2024
每年研究成果
概覽
指紋
網路
研究成果
(97)
類似的個人檔案
(6)
指紋
查看啟用 Shyh-Kuan Tai 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Advanced Hypopharyngeal Cancer
14%
Aggressiveness
10%
BMI1
15%
Cancer Cells
31%
Cancer Patients
10%
Carotid Blowout Syndrome
19%
Cetuximab
30%
Chemoradiotherapy
21%
Cisplatin
23%
Cisplatin Treatment
10%
Cisplatin-based Chemotherapy
10%
Concurrent Chemoradiotherapy
14%
Decoy Receptor 3 (DcR3)
14%
Definitive Chemoradiotherapy (dCRT)
12%
Disease-specific Survival
16%
Distant Metastasis
20%
Epithelial-mesenchymal Transition
35%
Flap Reconstruction
11%
General Anesthesia
10%
Head-and-neck
19%
Head-and-neck Cancer
100%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
75%
Hypopharynx
9%
Hypoxia
14%
Hypoxia-inducible factor-1α (HIF-1α)
11%
Induction Chemotherapy
16%
Laryngotracheal
9%
Local Recurrence
12%
Lymphovascular Invasion
10%
Macrophages
10%
Neck Dissection
32%
Nm23
14%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
88%
Overall Survival
13%
Papillary Thyroid Carcinoma
11%
Perineural Invasion
42%
Phase II Study
14%
Prognostic Indicator
10%
Pyriform Sinus Fistula
9%
Radiotherapy
16%
Recurrent Metastatic
19%
Results of Surgery
9%
Salvage Treatment
10%
Second Primary Malignancy
13%
Squamous Carcinoma Cells
13%
Tonsillar Squamous Cell Carcinoma
19%
Tumor
29%
Tumor Progression
12%
Tumor-associated Macrophages
16%
Twist1
15%
Medicine and Dentistry
Adjuvant Therapy
14%
Base
7%
Bleeding
7%
Carotid Blowout Syndrome
19%
Chemoradiotherapy
29%
Cisplatin
11%
Clinical Significance
6%
Disease Free Survival
10%
Disease Specific Survival
14%
Diseases
18%
Distant Metastasis
15%
Fistula
12%
Head and Neck Cancer
41%
Head and Neck Squamous Cell Carcinoma
36%
Hypopharyngeal Cancer
20%
Hypopharynx
9%
Image Enhanced Endoscopy
6%
Induction Chemotherapy
10%
Laryngectomy
10%
Larynx
13%
Lymph Node Metastasis
10%
Lymphovascular Invasion
10%
Malignant Neoplasm
12%
Metastatic Carcinoma
11%
Mouth Squamous Cell Carcinoma
59%
Narrow Band Imaging
7%
Neck
35%
Neck Dissection
32%
Neoplasm
43%
Oral Cancer
8%
Oral Cavity
7%
Overall Survival
14%
Papillary Thyroid Cancer
14%
Perineural Invasion
42%
Piriform Sinus
11%
Primary Tumor
9%
Prognostic Factor
10%
Radiation Therapy
28%
Recurrent Disease
29%
Second Cancer
19%
Snail
10%
Squamous Cell Carcinoma
29%
Squamous Cell Carcinoma Cell
8%
Stent-Graft
9%
Surgery
7%
Survival Rate
14%
Tongue
19%
Tongue Carcinoma
14%
Tonsil Carcinoma
9%
Vocal Folds
10%
